Skip to content
Cultural Foundation
Author:
Precision Diagnostics
Precision Diabetes and DirectSens Partner to Launch MetMark™ AHB Test in the U.S.
September 23, 2026
Precision Diabetes and Nagase Diagnostics Announce Exclusive U.S. Commercialization Partnership for Lucica® Glycated Albumin-L, the Only FDA-Cleared Assay Specifically Measured Glycated Albumin in the United States
July 23, 2026
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
June 5, 2026
Precision Diagnostics Publishes Groundbreaking Whitepaper on DNA-Based Urine Specimen Verification, Advancing Accuracy and Patient Experience in Toxicology Testing
April 16, 2026